University of Western Australia, Crawley, Western Australia, Australia.
Department of Oral Medicine and Surgery, Faculty of Dentistry, Jordan University of Science and Technology, Irbid, Jordan.
Oral Dis. 2019 Jun;25 Suppl 1:182-192. doi: 10.1111/odi.13074.
To evaluate the current evidence regarding the effectiveness of non-opioid interventions for the therapeutic management of pain in head and neck cancer patients with oral mucositis resulting from radiotherapy only or chemoradiotherapy.
A literature search was conducted which included randomised controlled trials that assessed patient-related outcome of pain in patients with oral mucositis associated with radiation therapy only or chemoradiotherapy. Literature searches were conducted in MEDLINE via Pubmed, Embase, Scopus and CINAHL.
The electronic searches identified 846 articles. Screening revealed that six articles met all eligibility inclusion criteria. Interventions showing statistically significant benefits to reduce oral mucositis associated pain compared to placebo included doxepin (p < 0.001, 95% CI -6.7 to -2.1), amitriptyline (p = 0.04), diclofenac (p < 0.01) and benzydamine (p = 0.014).
Non-opioid interventions, including topical doxepin, amitriptyline, diclofenac and benzydamine, were found to provide relief of pain due to mucositis, and when effective may allow for reduction in the use of opioids in pain management.
评估仅放疗或放化疗所致头颈部癌口腔黏膜炎患者疼痛治疗中,非阿片类干预措施的有效性的现有证据。
进行了文献检索,包括评估与单纯放疗或放化疗相关的口腔黏膜炎患者疼痛的患者相关结局的随机对照试验。在 MEDLINE 中通过 Pubmed、Embase、Scopus 和 CINAHL 进行了文献检索。
电子检索确定了 846 篇文章。筛选显示,有 6 篇文章符合所有纳入标准。与安慰剂相比,显示出减轻口腔黏膜炎相关疼痛有统计学意义的益处的干预措施包括多塞平(p<0.001,95%CI-6.7 至-2.1)、阿米替林(p=0.04)、双氯芬酸(p<0.01)和苯佐卡因(p=0.014)。
非阿片类干预措施,包括局部多塞平、阿米替林、双氯芬酸和苯佐卡因,可缓解黏膜炎引起的疼痛,而且在有效时可能会减少阿片类药物在疼痛管理中的使用。